Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril

NCT02654678 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure
Dilated Cardiomyopathy
Congenital Heart Disease

Interventions

DRUG: Enalapril Orodispersible Minitablet

Sponsor

Ethicare GmbH